These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 36330636)
1. Ribosome-inactivating Protein MAP30 Isolated from Zhou Y; Yang D; Qiang Z; Meng Y; Li R; Fan X; Zhao W; Meng Y Recent Pat Anticancer Drug Discov; 2024; 19(2):223-232. PubMed ID: 36330636 [TBL] [Abstract][Full Text] [Related]
2. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol. Meng Y; Liu S; Li J; Meng Y; Zhao X Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682 [TBL] [Abstract][Full Text] [Related]
3. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Fan X; He L; Meng Y; Li G; Li L; Meng Y Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293 [TBL] [Abstract][Full Text] [Related]
4. Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells. Hlin H; Zhi-Guo Z; Cong-Hui H; Yan Z; Qing L; Bo J; Hou-Guang H; Jun-Jie Z; Pei-Ying Z Minerva Urol Nefrol; 2016 Jun; 68(3):275-81. PubMed ID: 25517785 [TBL] [Abstract][Full Text] [Related]
5. The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo. Fang EF; Zhang CZ; Wong JH; Shen JY; Li CH; Ng TB Cancer Lett; 2012 Nov; 324(1):66-74. PubMed ID: 22579806 [TBL] [Abstract][Full Text] [Related]
6. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis. Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169 [TBL] [Abstract][Full Text] [Related]
7. A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L. Meng Y; Lin S; Liu S; Fan X; Li G; Meng Y PLoS One; 2014; 9(7):e101998. PubMed ID: 25003606 [TBL] [Abstract][Full Text] [Related]
8. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity. Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613 [TBL] [Abstract][Full Text] [Related]
9. MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells. Qian S; Sun L; Li J; Wu J; Hu G; Han Y; Yu K; Zhang S Oncol Rep; 2016 Jun; 35(6):3705-13. PubMed ID: 27035419 [TBL] [Abstract][Full Text] [Related]
10. Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity. Sun Y; Sun F; Li J; Wu M; Fan X; Meng Y; Meng Y Molecules; 2016 Oct; 21(11):. PubMed ID: 27809255 [TBL] [Abstract][Full Text] [Related]
11. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Puri M; Kaur I; Kanwar RK; Gupta RC; Chauhan A; Kanwar JR Curr Mol Med; 2009 Dec; 9(9):1080-94. PubMed ID: 19747115 [TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells. Fan JM; Luo J; Xu J; Zhu S; Zhang Q; Gao DF; Xu YB; Zhang GP Mol Biotechnol; 2008 May; 39(1):79-86. PubMed ID: 18246454 [TBL] [Abstract][Full Text] [Related]
13. [Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity]. Zhang LL; Ding Q; Zhan JB Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):264-71. PubMed ID: 20544988 [TBL] [Abstract][Full Text] [Related]
14. Recombinant anti-HIV MAP30, a ribosome inactivating protein: against plant virus and bacteriophage. Amirzadeh N; Moghadam A; Niazi A; Afsharifar A Sci Rep; 2023 Feb; 13(1):2091. PubMed ID: 36747030 [TBL] [Abstract][Full Text] [Related]
15. MAP30 and luffin-α: Novel ribosome-inactivating proteins induce plant systemic resistance against plant viruses. Wei Z; Yang L; Liu W; Xu X; Ran M; Jin Y; Sun X Pestic Biochem Physiol; 2023 Apr; 191():105342. PubMed ID: 36963924 [TBL] [Abstract][Full Text] [Related]
16. MAP30 Inhibits Bladder Cancer Cell Migration and Invasion Zhang S; Shi Z; Pang K; He H; Chen J; Zhang Z; Zhang Q; Hao L; Han C DNA Cell Biol; 2020 Nov; 39(11):1948-1960. PubMed ID: 33155841 [TBL] [Abstract][Full Text] [Related]
17. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery. Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168 [TBL] [Abstract][Full Text] [Related]
18. Antitumor mechanism of MAP30 in bladder cancer T24 cells, and its potential toxic effects in mice. Shi Z; Pang K; Yang W; Zhou J; Dong B; Zhang Z; Zhao Y; Han C; Hao L Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):42-48. PubMed ID: 32359382 [TBL] [Abstract][Full Text] [Related]
19. Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity. Lv Q; Yang XZ; Fu LY; Lu YT; Lu YH; Zhao J; Wang FJ Protein Expr Purif; 2015 Jul; 111():9-17. PubMed ID: 25797209 [TBL] [Abstract][Full Text] [Related]
20. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma. Baek SY; Hwang UW; Suk HY; Kim YW Biomolecules; 2020 May; 10(5):. PubMed ID: 32375410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]